113 related articles for article (PubMed ID: 17846598)
21. [Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive heart failure].
Saito M; Hayashi T; Nojima M; Ikeda H; Tarasawa I; Yasui H; Ishida T; Adachi M; Imai K; Shinomura Y
Rinsho Ketsueki; 2007 Nov; 48(11):1478-83. PubMed ID: 18080505
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
23. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
24. Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.
Irazabal MV; Eirin A; Gertz MA; Dispenzieri A; Kumar S; Buadi FK; Lacy MQ; Hayman SR; Dingli D; Hogan WJ; Gastineau DA; Glavey SV; Amer H; Leung N
Am J Hematol; 2012 Jan; 87(1):51-4. PubMed ID: 22076913
[TBL] [Abstract][Full Text] [Related]
25. Transplantation for amyloidosis.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
[TBL] [Abstract][Full Text] [Related]
26. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
27. [Autologous stem cell transplantation in the treatment of primary systemic amyloidosis].
Gil L; Komarnicki M
Pol Merkur Lekarski; 2009 Sep; 27(159):181-4. PubMed ID: 19827724
[TBL] [Abstract][Full Text] [Related]
28. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
[TBL] [Abstract][Full Text] [Related]
29. [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support].
Schjesvold FH; Sjo M; Tangen JM; Hammerstrøm J; Brinch L
Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1392-6. PubMed ID: 18552900
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Rosenbaum C; Peace D; Rich E; Van Besien K
Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
[TBL] [Abstract][Full Text] [Related]
31. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
[TBL] [Abstract][Full Text] [Related]
32. Optimal use of G-CSF administration after hematopoietic SCT.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
Bone Marrow Transplant; 2009 Jun; 43(12):895-908. PubMed ID: 19363527
[TBL] [Abstract][Full Text] [Related]
33. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
Kroschinsky F; Hölig K; Ehninger G
Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
[TBL] [Abstract][Full Text] [Related]
34. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
36. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
[TBL] [Abstract][Full Text] [Related]
37. Early identification and management of graft failure after unrelated cord blood transplantation.
Chan KW; Grimley MS; Taylor C; Wall DA
Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
[TBL] [Abstract][Full Text] [Related]
38. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
[TBL] [Abstract][Full Text] [Related]
39. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
Russell N; Mesters R; Schubert J; Boogaerts M; Johnsen HE; Canizo CD; Baker N; Barker P; Skacel T; Schmitz N
Haematologica; 2008 Mar; 93(3):405-12. PubMed ID: 18268285
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.
Di Campli C; Zocco MA; Saulnier N; Grieco A; Rapaccini G; Addolorato G; Rumi C; Santoliquido A; Leone G; Gasbarrini G; Gasbarrini A
Dig Liver Dis; 2007 Dec; 39(12):1071-6. PubMed ID: 17964871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
